Tag Archives: IPO readiness

SCHOTT Pharma Extends CEO Andreas Reisse’s Tenure to 2026 While Appointing Reinhard Mayer as CFO

(IN BRIEF) SCHOTT Pharma’s Supervisory Board has prolonged CEO Andreas Reisse’s mandate until April 2026, reflecting his pivotal role in driving the company’s emergence as a world-leading manufacturer of pharmaceutical containment and delivery systems. CFO Dr. Almuth Steinkühler will step … Read the full press release